Shionogi & Co., Ltd.
4507Pharmaceuticals
¥2,989.00−0.07%As of Oct 29vs prior close
- Market cap
- $16.1B
- P/E (TTM)
- 9.7×
- P/E (FY1)
- 11.0×
- From 52W high
- −16.50%
- EPS (LTM)
- ¥311.10
- Revenue (LTM)
- ¥563.2B
- Net margin
- 46.79%
- Dividend yield
- 2.54%
Nomior Score
57
Steady ProfileTop 33% of the scored universe
Growth43
Quality49
Value61
Momentum65
Resilience56
Growth
+5.40%revenue a year over 3 fiscal years
YE23 ¥426.7BLTM ¥563.2B
Connections
Revenue to profitYE26
41% of revenue became net profit, up 2 pts on a year.